Sodium in PDB 8a0b: Inhibitor Binding to HDAC2
Enzymatic activity of Inhibitor Binding to HDAC2
All present enzymatic activity of Inhibitor Binding to HDAC2:
3.5.1.98;
Protein crystallography data
The structure of Inhibitor Binding to HDAC2, PDB code: 8a0b
was solved by
A.Cleasby,
D.Tisi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
67.17 /
1.75
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.221,
98.018,
139.402,
90,
90,
90
|
R / Rfree (%)
|
16.5 /
18.8
|
Other elements in 8a0b:
The structure of Inhibitor Binding to HDAC2 also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Inhibitor Binding to HDAC2
(pdb code 8a0b). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
Inhibitor Binding to HDAC2, PDB code: 8a0b:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 8a0b
Go back to
Sodium Binding Sites List in 8a0b
Sodium binding site 1 out
of 3 in the Inhibitor Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Inhibitor Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na603
b:27.8
occ:1.00
|
O
|
A:PHE192
|
2.2
|
25.2
|
1.0
|
O
|
A:VAL198
|
2.3
|
26.8
|
1.0
|
O
|
A:HOH799
|
2.4
|
27.6
|
1.0
|
O
|
A:THR195
|
2.4
|
27.7
|
1.0
|
O
|
A:HOH821
|
3.0
|
36.4
|
1.0
|
C
|
A:PHE192
|
3.3
|
24.9
|
1.0
|
C
|
A:VAL198
|
3.6
|
26.3
|
1.0
|
O
|
A:TYR227
|
3.6
|
26.0
|
1.0
|
C
|
A:THR195
|
3.6
|
29.0
|
1.0
|
CB
|
A:TYR227
|
3.7
|
26.2
|
1.0
|
CB
|
A:PHE192
|
3.9
|
25.4
|
1.0
|
C
|
A:TYR227
|
4.2
|
26.2
|
1.0
|
N
|
A:THR195
|
4.2
|
29.8
|
1.0
|
CG2
|
A:THR195
|
4.2
|
28.7
|
1.0
|
CA
|
A:PHE192
|
4.2
|
24.6
|
1.0
|
N
|
A:TYR193
|
4.3
|
25.6
|
1.0
|
CA
|
A:TYR193
|
4.3
|
26.2
|
1.0
|
C
|
A:TYR193
|
4.3
|
27.4
|
1.0
|
CA
|
A:THR195
|
4.4
|
29.5
|
1.0
|
O
|
A:TYR193
|
4.4
|
27.7
|
1.0
|
N
|
A:MET199
|
4.5
|
24.8
|
1.0
|
CA
|
A:VAL198
|
4.5
|
24.3
|
1.0
|
CA
|
A:MET199
|
4.5
|
22.8
|
1.0
|
CA
|
A:TYR227
|
4.6
|
25.7
|
1.0
|
N
|
A:VAL198
|
4.6
|
24.7
|
1.0
|
CA
|
A:GLY224
|
4.6
|
29.5
|
1.0
|
CB
|
A:VAL198
|
4.6
|
23.4
|
1.0
|
N
|
A:ASP196
|
4.7
|
30.1
|
1.0
|
O
|
A:GLY224
|
4.7
|
26.0
|
1.0
|
N
|
A:THR194
|
4.9
|
27.3
|
1.0
|
CA
|
A:ASP196
|
4.9
|
29.1
|
1.0
|
N
|
A:THR200
|
4.9
|
23.3
|
1.0
|
CB
|
A:THR195
|
4.9
|
31.1
|
1.0
|
N
|
A:ALA228
|
4.9
|
25.5
|
1.0
|
CG
|
A:TYR227
|
4.9
|
27.7
|
1.0
|
|
Sodium binding site 2 out
of 3 in 8a0b
Go back to
Sodium Binding Sites List in 8a0b
Sodium binding site 2 out
of 3 in the Inhibitor Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Inhibitor Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na603
b:26.5
occ:1.00
|
O
|
B:PHE192
|
2.3
|
24.9
|
1.0
|
O
|
B:VAL198
|
2.3
|
25.1
|
1.0
|
O
|
B:HOH803
|
2.4
|
23.1
|
1.0
|
O
|
B:THR195
|
2.4
|
26.0
|
1.0
|
O
|
B:HOH795
|
2.8
|
31.9
|
1.0
|
C
|
B:PHE192
|
3.4
|
24.3
|
1.0
|
O
|
B:TYR227
|
3.5
|
26.6
|
1.0
|
C
|
B:VAL198
|
3.6
|
24.1
|
1.0
|
C
|
B:THR195
|
3.7
|
26.1
|
1.0
|
CB
|
B:TYR227
|
3.7
|
25.6
|
1.0
|
CB
|
B:PHE192
|
4.0
|
24.1
|
1.0
|
C
|
B:TYR227
|
4.1
|
26.3
|
1.0
|
N
|
B:THR195
|
4.2
|
27.2
|
1.0
|
CG2
|
B:THR195
|
4.2
|
27.4
|
1.0
|
N
|
B:TYR193
|
4.3
|
24.6
|
1.0
|
CA
|
B:PHE192
|
4.3
|
23.6
|
1.0
|
CA
|
B:TYR193
|
4.3
|
24.2
|
1.0
|
C
|
B:TYR193
|
4.3
|
25.8
|
1.0
|
O
|
B:TYR193
|
4.3
|
26.7
|
1.0
|
CA
|
B:THR195
|
4.4
|
26.6
|
1.0
|
N
|
B:MET199
|
4.5
|
22.3
|
1.0
|
CA
|
B:MET199
|
4.5
|
22.0
|
1.0
|
CA
|
B:VAL198
|
4.5
|
22.9
|
1.0
|
CA
|
B:TYR227
|
4.5
|
25.2
|
1.0
|
N
|
B:VAL198
|
4.6
|
24.4
|
1.0
|
CA
|
B:GLY224
|
4.6
|
28.8
|
1.0
|
O
|
B:GLY224
|
4.7
|
26.5
|
1.0
|
CB
|
B:VAL198
|
4.7
|
22.5
|
1.0
|
N
|
B:ASP196
|
4.7
|
24.7
|
1.0
|
N
|
B:THR194
|
4.8
|
26.6
|
1.0
|
N
|
B:ALA228
|
4.9
|
24.1
|
1.0
|
N
|
B:THR200
|
4.9
|
21.1
|
1.0
|
CA
|
B:ASP196
|
4.9
|
26.0
|
1.0
|
CG
|
B:TYR227
|
4.9
|
25.9
|
1.0
|
CB
|
B:THR195
|
5.0
|
27.7
|
1.0
|
|
Sodium binding site 3 out
of 3 in 8a0b
Go back to
Sodium Binding Sites List in 8a0b
Sodium binding site 3 out
of 3 in the Inhibitor Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Inhibitor Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Na603
b:30.3
occ:1.00
|
O
|
C:VAL198
|
2.3
|
29.4
|
1.0
|
O
|
C:PHE192
|
2.3
|
26.9
|
1.0
|
O
|
C:THR195
|
2.3
|
29.4
|
1.0
|
O
|
C:HOH772
|
2.3
|
27.0
|
1.0
|
O
|
C:HOH788
|
2.9
|
41.3
|
1.0
|
C
|
C:PHE192
|
3.4
|
26.1
|
1.0
|
C
|
C:VAL198
|
3.5
|
28.7
|
1.0
|
C
|
C:THR195
|
3.5
|
29.6
|
1.0
|
O
|
C:TYR227
|
3.6
|
31.1
|
1.0
|
CB
|
C:TYR227
|
3.7
|
31.3
|
1.0
|
CB
|
C:PHE192
|
4.0
|
25.8
|
1.0
|
N
|
C:THR195
|
4.1
|
29.3
|
1.0
|
C
|
C:TYR227
|
4.1
|
31.9
|
1.0
|
CG2
|
C:THR195
|
4.2
|
28.3
|
1.0
|
CA
|
C:PHE192
|
4.3
|
25.4
|
1.0
|
CA
|
C:THR195
|
4.3
|
28.8
|
1.0
|
C
|
C:TYR193
|
4.4
|
28.0
|
1.0
|
N
|
C:TYR193
|
4.4
|
25.4
|
1.0
|
CA
|
C:TYR193
|
4.4
|
26.1
|
1.0
|
O
|
C:TYR193
|
4.4
|
29.0
|
1.0
|
N
|
C:MET199
|
4.4
|
27.8
|
1.0
|
CA
|
C:MET199
|
4.4
|
27.7
|
0.5
|
CA
|
C:MET199
|
4.4
|
27.2
|
0.5
|
CA
|
C:VAL198
|
4.5
|
27.4
|
1.0
|
CA
|
C:TYR227
|
4.5
|
30.7
|
1.0
|
N
|
C:VAL198
|
4.5
|
28.1
|
1.0
|
CA
|
C:GLY224
|
4.5
|
29.6
|
1.0
|
N
|
C:ASP196
|
4.6
|
28.9
|
1.0
|
O
|
C:GLY224
|
4.6
|
29.0
|
1.0
|
CB
|
C:VAL198
|
4.7
|
26.5
|
1.0
|
CA
|
C:ASP196
|
4.8
|
30.1
|
1.0
|
CG
|
C:TYR227
|
4.8
|
32.6
|
1.0
|
N
|
C:THR194
|
4.9
|
26.5
|
1.0
|
CB
|
C:THR195
|
4.9
|
29.9
|
1.0
|
N
|
C:ALA228
|
4.9
|
31.1
|
1.0
|
N
|
C:THR200
|
4.9
|
26.5
|
1.0
|
|
Reference:
E.Tamanini,
S.Miyamura,
I.M.Buck,
B.D.Cons,
L.Dawson,
C.East,
T.Futamura,
S.Goto,
C.Griffiths-Jones,
T.Hashimoto,
T.D.Heightman,
S.Ishikawa,
H.Ito,
Y.Kaneko,
T.Kawato,
K.Kondo,
N.Kurihara,
J.M.Mccarthy,
Y.Mori,
T.Nagase,
Y.Nakaishi,
J.Reeks,
A.Sato,
P.Schopf,
K.Tai,
T.Tamai,
D.Tisi,
A.J.Woolford.
Fragment-Based Discovery of A Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor. Acs Med.Chem.Lett. V. 13 1591 2022.
ISSN: ISSN 1948-5875
PubMed: 36262388
DOI: 10.1021/ACSMEDCHEMLETT.2C00272
Page generated: Wed Oct 9 10:21:41 2024
|